v3.26.1
Stockholders’ Deficit (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Redeemable Common Stock

The activity of the redeemable common stock is as follows:

 

Value upon share issuance on December 15, 2025  $1,228 
Less: decrease in value through March 31, 2026   (328)
Plus: increase in value through May 26, 2026   63 
Redeemable stock reclassified to permanent equity on May 26, 2026  $963 
Schedule of Assets Acquired and Liabilities Assumed

The following are the fair values of major classes of assets acquired and liabilities assumed as of the May 26, 2026 acquisition date (in thousands of dollars):

 

     
Assets acquired:     
Receivable from DNA Holdings   109 
Intangible assets-software   1,100 
Intangible assets-trademarks   185 
Total asset   1,394 
      
Liabilities assumed:     
Accounts payable   104 
      
Net assets acquired  $1,290 
      
Derecognition of equity investment  $1,290